for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

aTyr Pharma Inc

LIFE.PH

Latest Trade

3.02USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

2.92

 - 

10.01

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Atyr Posts Qtrly Loss Per Share Of $1.80

Aug 14 (Reuters) - aTyr Pharma Inc <LIFE.O>::ATYR PHARMA ANNOUNCES SECOND QUARTER 2019 RESULTS AND PROVIDES CORPORATE UPDATE.QTRLY LOSS PER SHARE $1.80.AS OF JUNE 30, 2019, ATYR HAD $42.4 MILLION IN CASH, CASH EQUIVALENTS AND INVESTMENTS.TO REPORT INTERIM SAFETY RESULTS FROM PHASE 1B/2A PROOF-OF-CONCEPT TRIAL OF ATYR1923 IN PULMONARY SARCOIDOSIS PATIENTS IN Q4 2019.

Atyr Pharma Announces Reverse Stock Split To Regain Nasdaq Compliance

June 28 (Reuters) - aTyr Pharma Inc <LIFE.O>::ATYR PHARMA ANNOUNCES REVERSE STOCK SPLIT TO REGAIN NASDAQ COMPLIANCE.ANNOUNCES 1 FOR 14 REVERSE STOCK SPLIT.PAR VALUE OF COMPANY'S COMMON STOCK WILL REMAIN UNCHANGED AT $0.001 PER SHARE AFTER REVERSE STOCK SPLIT.ONE-FOR-14 REVERSE STOCK SPLIT IS SCHEDULED TO BECOME EFFECTIVE AFTER TRADING CLOSES ON JUNE 28, 2019.

Atyr Pharma Files For Mixed Shelf Of Up To $20 Million – SEC Filing

May 22 (Reuters) - aTyr Pharma Inc <LIFE.O>::ATYR PHARMA INC FILES FOR MIXED SHELF OF UP TO $20 MILLION – SEC FILING.

aTyr Pharma Qtrly Loss Per Share $0.18

May 13 (Reuters) - aTyr Pharma Inc <LIFE.O>::ATYR PHARMA ANNOUNCES FIRST QUARTER 2019 RESULTS AND PROVIDES CORPORATE UPDATE.ATYR PHARMA INC - QTRLY LOSS PER SHARE $0.18.ATYR PHARMA INC - AS OF MARCH 31, 2019, ATYR HAD $43.0 MILLION IN CASH, CASH EQUIVALENTS AND INVESTMENTS..ATYR PHARMA - SUBSEQUENT TO QUARTER-END, CO RAISED $5 MILLION IN GROSS PROCEEDS THROUGH REGISTERED DIRECT INVESTMENT LED BY FEDERATED KAUFMANN SMALL CAP FUND.

Atyr Pharma Announces Fourth Quarter Results

March 25 (Reuters) - aTyr Pharma Inc <LIFE.O>::ATYR PHARMA ANNOUNCES FOURTH QUARTER AND FULL YEAR 2018 RESULTS AND PROVIDES CORPORATE UPDATE.ATYR PHARMA INC - AS OF DECEMBER 31, 2018, ATYR HAD $49.5 MILLION IN CASH, CASH EQUIVALENTS AND INVESTMENTS.ATYR PHARMA - AS OF DEC 31, 2018, CO HAD $49.5 MILLION IN CASH, CASH EQUIVALENTS & INVESTMENTS.ATYR PHARMA INC - FOR 2019, CO PROJECTING CASH BURN OF ABOUT $23 MILLION TO $25 MILLION, NET OF DEBT.

ATyr Pharma Announces Research Collaboration With Global Biotherapeutics Leader CSL Behring

March 11 (Reuters) - aTyr Pharma Inc <LIFE.O>::ATYR PHARMA ANNOUNCES RESEARCH COLLABORATION WITH GLOBAL BIOTHERAPEUTICS LEADER CSL BEHRING.ATYR PHARMA INC - ATYR ELIGIBLE TO RECEIVE UP TO $17 MILLION IN POTENTIAL OPTION FEES.ATYR PHARMA INC - CSL BEHRING WILL PAY A TOTAL OF UP TO $4.25 MILLION PER SYNTHETASE PROGRAM.ATYR PHARMA - ATYR WILL GRANT CSL BEHRING OPTION TO NEGOTIATE LICENSES FOR WORLDWIDE RIGHTS TO EACH IND CANDIDATE THAT EMERGES FROM COLLABORATION.

aTyr Pharma Announces Third Quarter 2018 Operating Results

Nov 13 (Reuters) - aTyr Pharma Inc <LIFE.O>::ATYR PHARMA ANNOUNCES THIRD QUARTER 2018 OPERATING RESULTS AND PROVIDES CORPORATE UPDATE.ATYR PHARMA INC - INITIATION OF PROOF-OF-CONCEPT STUDY IN PATIENTS WITH PULMONARY SARCOIDOSIS PLANNED FOR Q4 OF 2018.ATYR PHARMA INC - QTRLY LOSS PER SHARE $0.24.

Paul Schimmel Reports A 5.3 Pct Stake In Atyr Pharma As Of Aug. 30

Sept 10 (Reuters) - aTyr Pharma Inc <LIFE.O>::AS OF AUG. 30 - SEC FILING.PAUL SCHIMMEL SAYS ACQUIRED ATYR PHARMA'S SHARES FOR INVESTMENT ON BELIEF THAT SUCH SHARES REPRESENTED "AN ATTRACTIVE INVESTMENT OPPORTUNITY".

Atyr Pharma Announces Q2 2018 Operating Results

Aug 14 (Reuters) - aTyr Pharma Inc <LIFE.O>::ATYR PHARMA ANNOUNCES SECOND QUARTER 2018 OPERATING RESULTS AND PROVIDES CORPORATE UPDATE.ATYR PHARMA INC - QTRLY LOSS PER SHARE $0.35.

Atyr Pharma Appoints Jill Broadfoot As CFO

July 31 (Reuters) - aTyr Pharma Inc <LIFE.O>::ATYR PHARMA APPOINTS JILL BROADFOOT AS CHIEF FINANCIAL OFFICER.ATYR PHARMA INC - JILL BROADFOOT HAS JOINED ATYR AS CHIEF FINANCIAL OFFICER.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up